Applied dna announces closing of $15 million registered direct offering priced at-the-market under nasdaq rules

Stony brook, n.y.--(business wire)---- $apdn #covid19--applied dna sciences, inc. (nasdaq: apdn) (the “company”), a leader in polymerase chain reaction (pcr)-based dna manufacturing, announced today the closing of its previously announced registered direct offering with a group of institutional investors of 1,810,000 shares of common stock at a price of $8.30 per share, priced at-the-market under nasdaq rules, resulting in total gross proceeds of approximately $15 million, before deducting the placement agent's f
APDN Ratings Summary
APDN Quant Ranking